News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Recordati S.p.A: Positive First Quarter 2008 Results, Sales and Income Increase
May 6, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
MILAN, ITALY--(Marketwire - May 06, 2008) - - Consolidated revenue EUR 171.9 million, + 5.2%. - Pharmaceutical revenue EUR 163.4 million, + 6.3%. - International sales EUR 116.7 million, + 9.3%.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Europe
MORE ON THIS TOPIC
Layoff Tracker
Vistagen cuts workforce for second time in 2026
November 2, 2026
·
114 min read
·
BioSpace Editorial Staff
Cell therapy
Cell therapy investment grows as safety events rankle Big Pharma’s CAR T autoimmune push
November 2, 2026
·
3 min read
·
Annalee Armstrong
Drug Development
Can Saudi Arabia’s burgeoning biotech hub withstand geopolitical pressures?
November 2, 2026
·
6 min read
·
Jennifer C. Smith-Parker
Earnings
AstraZeneca employs $1.5B cost savings to reinvest back into growth
October 30, 2026
·
3 min read
·
Annalee Armstrong